Chronic Cough “Comes of Age”: A Landmark Shift in Respiratory Medicine at the Inaugural ERS Cough Conference on July 29, 2026 Posted by
The Sentinel’s Role: Navigating Bipolar Disorder Through the Lens of Friendship and Early Intervention on July 29, 2026 Posted by
Boston Scientific Faces Strategic Reset: Sales Guidance Slashed Amid Market Headwinds on July 29, 2026 Posted by
The Silent Epidemic: Confronting the Escalating Crisis of Healthcare Burnout on July 29, 2026 Posted by
Chronic Cough “Comes of Age”: A Landmark Shift in Respiratory Medicine at the Inaugural ERS Cough Conference on July 29, 2026 Posted by
The Sentinel’s Role: Navigating Bipolar Disorder Through the Lens of Friendship and Early Intervention on July 29, 2026 Posted by
Posted in Digital Health Tools FTC Secures Landmark Antitrust Settlement with CVS Caremark: A New Era for Pharmacy Benefit Management on July 15, 2026
Posted in Medical Innovations FTC Secures Landmark Settlement with CVS Caremark: Reshaping the Pharmacy Benefit Management Landscape on July 15, 2026
Posted in Sleep Health Nexalin Technology Secures Landmark Patent for Deep-Brain Neurostimulation, Targeting 2042 Market Dominance on July 11, 2026
Posted in Digital Health Tools Closing the "Missing Middle": Handspring Secures $19M to Revolutionize Pediatric Mental Health on July 11, 2026
Posted in Sleep Health Scaling the Silence: Ognomy Secures $20 Million to Transform the Future of Sleep Medicine on July 9, 2026
Posted in Digital Health Tools Pearl Health Secures $110 Million to Scale AI-Driven Value-Based Care Revolution on July 9, 2026
Posted in Medical Innovations MeiraGTx Secures $400 Million Lifeline from Oberland Capital to Accelerate Gene Therapy Portfolio on July 7, 2026
Posted in Sleep Health Bridging the Gap: OxiWear Secures Insurance Reimbursement to Democratize Continuous Oxygen Monitoring on July 6, 2026
Posted in Digital Health Tools Celea Therapeutics Secures $180 Million to Challenge the Status Quo in IPF Treatment on July 5, 2026
Posted in Medical Innovations Celea Therapeutics Secures $180M to Advance Next-Generation IPF Treatment on July 2, 2026
